CSBR vs PCAR · P/E 16, rev $59.4M vs P/E 25, rev $33.66B
Champions Oncology Inc (CSBR) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the CSBR and PCAR stock pages for the full models.
Not investment advice.